product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
p14 ARF (4C6/4) Mouse mAb
catalog :
2407
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
4C6/4
reactivity :
human, mouse
application :
western blot, immunohistochemistry, immunohistochemistry - paraffin section, proximity ligation assay
citations: 13
Published Application/Species/Sample/DilutionReference
  • western blot; mouse; loading ...; fig 6d
Samuel M, Fonseka P, Sanwlani R, Gangoda L, Chee S, Keerthikumar S, et al. Oral administration of bovine milk-derived extracellular vesicles induces senescence in the primary tumor but accelerates cancer metastasis. Nat Commun. 2021;12:3950 pubmed publisher
  • western blot; human; 1:1000; loading ...; fig s2d
Gao L, Hu Y, Tian Y, Fan Z, Wang K, Li H, et al. Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition. Nat Commun. 2019;10:1665 pubmed publisher
  • immunohistochemistry; human; 1:50; loading ...; fig 2h
Xie Y, Fan H, Lu W, Yang Q, Nurkesh A, Yeleussizov T, et al. Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer. Oncogene. 2019;38:2967-2983 pubmed publisher
  • western blot; human; loading ...; fig 2c
Juhasz A, Markel S, Gaur S, Liu H, Lu J, Jiang G, et al. NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction. J Biol Chem. 2017;292:7866-7887 pubmed publisher
  • western blot; human; fig S1B
Ding X, Jiang W, Zhou P, Liu L, Wan X, Yuan X, et al. Mixed Lineage Leukemia 5 (MLL5) Protein Stability Is Cooperatively Regulated by O-GlcNac Transferase (OGT) and Ubiquitin Specific Protease 7 (USP7). PLoS ONE. 2015;10:e0145023 pubmed publisher
  • proximity ligation assay; human; 1:100; fig 7c
Wang L, Liu R, Ye P, Wong C, Chen G, Zhou P, et al. Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation. Nat Commun. 2015;6:5909 pubmed publisher
Xie Y, Lu W, Liu S, Yang Q, Goodwin J, Sathyanarayana S, et al. MMP7 interacts with ARF in nucleus to potentiate tumor microenvironments for prostate cancer progression in vivo. Oncotarget. 2016;7:47609-47619 pubmed publisher
Hesse R, Kouklis G, Ahituv N, Pomerantz J. The human ARF tumor suppressor senses blastema activity and suppresses epimorphic tissue regeneration. elife. 2015;4: pubmed publisher
Kong L, Hao Q, Wang Y, Zhou P, Zou B, Zhang Y. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells. Oncotarget. 2015;6:28371-88 pubmed publisher
Lo D, Zhang Y, Dai M, Sun X, Zeng S, Lu H. Nucleostemin stabilizes ARF by inhibiting the ubiquitin ligase ULF. Oncogene. 2015;34:1688-97 pubmed publisher
Lu W, Xie Y, Ma Y, Matusik R, Chen Z. ARF represses androgen receptor transactivation in prostate cancer. Mol Endocrinol. 2013;27:635-48 pubmed publisher
To K, Pajovic S, Gallie B, Thériault B. Regulation of p14ARF expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma development. BMC Cancer. 2012;12:69 pubmed publisher
Shao C, Folkard M, Held K, Prise K. Estrogen enhanced cell-cell signalling in breast cancer cells exposed to targeted irradiation. BMC Cancer. 2008;8:184 pubmed publisher
product information
SKU :
2407S
Product-Name :
p14 ARF (4C6/4) Mouse mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Immunohistochemistry (Paraffin)
Product-Category :
Cell Cycle / Checkpoint Control
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
14
Host :
Mouse
Target :
p14 Arf
Primary-Protein :
p14ARF
Alt-Names :
ARF,CD2A2,CDK4 inhibitor p16-INK4,CDK4I,CDKN2,CDKN2A,CMM2,Cyclin-dependent kinase inhibitor 2A, isoform 4,INK4,INK4a,MLM,MTS-1,MTS1,TP16,cell cycle negative regulator beta,cyclin-dependent kinase 4 inhibitor A,cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3,cyclin-dependent kinase inhibitor p16,multiple tumor suppressor 1,p14,p14ARF,p16,p16-INK4,p16-INK4a,p16INK4,p16INK4a,p19,p19ARF
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.